Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.8K Buy
928
+329
+55% +$21.9K ﹤0.01% 1081
2026
Q1
$37.6K Hold
599
﹤0.01% 1210
2025
Q4
$39.8K Buy
599
+129
+27% +$8.34K ﹤0.01% 1173
2025
Q3
$31.6K Sell
470
-864
-65% -$68.4K ﹤0.01% 1269
2025
Q2
$116K Buy
1,334
+652
+96% +$51.1K ﹤0.01% 768
2025
Q1
$46.6K Buy
682
+54
+9% +$4.41K ﹤0.01% 1005
2024
Q4
$48.8K Buy
+628
New +$46.5K ﹤0.01% 1002

Other funds holding DXCM

SBI Securities's DXCM Position: Q2 2026 in Review

SBI Securities increased its DexCom (DXCM) stake by 55% in Q2 2026, buying an estimated $21.9K and bringing the position to 928 shares worth $62.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1081.

SBI Securities first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $116K in Q2 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • SBI Securities held 928 shares of DexCom worth $62.8K as of Q2 2026.
  • SBI Securities bought 329 DexCom shares in Q2 2026, an estimated $21.9K.
  • DexCom made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1081 holding.
  • SBI Securities first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's DexCom position peaked at $116K in Q2 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.